Lingbing Li
Impact in
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Ubiquitin and proteasome pathways 3
- Cancer-related gene regulation 2
- Oncology 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Min Sun (1 shared paper)Zhimei Song (1 shared paper)Guangxi Zhai (1 shared paper)Runliang Feng (1 shared paper)Yan Gao (1 shared paper)Chenyu Guo (1 shared paper)Wei Xu (1 shared paper)Peixue Ling (1 shared paper)
- Journals
- Medicine (1 paper)Acta Pharmacologica Sinica (1 paper)Drug Delivery (1 paper)European Journal of Nuclear Medicine and Molecular Imaging (1 paper)Aging (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lingbing Li
14 papers receiving 450 citations
Peers
Comparison fields: 5 of 81
- Molecular Medicine 138
- Pharmaceutical Science 89
- Biomaterials 162
- Pharmacology 28
- Polymers and Plastics 24
Countries citing papers authored by Lingbing Li
This map shows the geographic impact of Lingbing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingbing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingbing Li more than expected).
Fields of papers citing papers by Lingbing Li
This network shows the impact of papers produced by Lingbing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingbing Li. The network helps show where Lingbing Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingbing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 290 | |
| 2 | 2012 | 29 | |
| 3 | 2023 | 22 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 16 | |
| 6 | 2021 | 16 | |
| 7 | 2013 | 15 | |
| 8 | 2016 | 13 | |
| 9 | 2022 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2017 | 7 | |
| 12 | 2024 | 6 | |
| 13 | 2024 | 4 | |
| 14 | 2025 | 2 | |
| 15 | 2025 | 0 |
About Lingbing Li
Lingbing Li is a scholar working on Molecular Biology, Oncology, Biomaterials, Biomedical Engineering and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 454 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Peptidase Inhibition and Analysis (2 papers), Advanced Drug Delivery Systems (2 papers), Cancer-related gene regulation (2 papers), Nanoplatforms for cancer theranostics (2 papers), Curcumin's Biomedical Applications (1 paper) and Optical Coherence Tomography Applications (1 paper). The work is most often cited by research in Molecular Medicine (138 citations), Pharmaceutical Science (89 citations), Biomaterials (162 citations), Pharmacology (28 citations) and Polymers and Plastics (24 citations). Lingbing Li has collaborated with scholars based in China and United States. Frequent co-authors include Min Sun, Zhimei Song, Guangxi Zhai, Runliang Feng, Yan Gao, Chenyu Guo, Wei Xu, Peixue Ling, Yanan Cui and Xiaolin Jiang. Their work appears in journals such as Medicine, Acta Pharmacologica Sinica, Drug Delivery, European Journal of Nuclear Medicine and Molecular Imaging and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.